柠檬酸铁在伊拉克血液透析患者样本中的作用-一项随机对照临床试验

Sumer 1 Pub Date : 2023-08-15 DOI:10.21931/rb/css/2023.08.01.78

Reyadh Jassem, F. Al-Hamadani, Haydar Fakhri Al-Tukmag, Saad John Hamza Al_mensory

{"title":"柠檬酸铁在伊拉克血液透析患者样本中的作用-一项随机对照临床试验","authors":"Reyadh Jassem, F. Al-Hamadani, Haydar Fakhri Al-Tukmag, Saad John Hamza Al_mensory","doi":"10.21931/rb/css/2023.08.01.78","DOIUrl":null,"url":null,"abstract":"Background: Uncontrolled hyperphosphatemia is the main difficulty\nfacing staff treating patients with end-stage renal disease on hemodialysis. Sevelamer and calcium-containing phosphate binders have been associated with cost\nburden and tissue calcification, respectively. Therefore, the current trial was targeted to investigate the efficacy of a new phosphate binder, ferric citrate, in a\nsample of Iraqi patients with end-stage renal disease on hemodialysis.\nKeywords: Ferric citrate, Hemodialysis Phosphate binder","PeriodicalId":443152,"journal":{"name":"Sumer 1","volume":"410 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The role of ferric citrate in a sample of Iraqi patients on hemodialysis- A randomized controlled clinical trial\",\"authors\":\"Reyadh Jassem, F. Al-Hamadani, Haydar Fakhri Al-Tukmag, Saad John Hamza Al_mensory\",\"doi\":\"10.21931/rb/css/2023.08.01.78\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Uncontrolled hyperphosphatemia is the main difficulty\\nfacing staff treating patients with end-stage renal disease on hemodialysis. Sevelamer and calcium-containing phosphate binders have been associated with cost\\nburden and tissue calcification, respectively. Therefore, the current trial was targeted to investigate the efficacy of a new phosphate binder, ferric citrate, in a\\nsample of Iraqi patients with end-stage renal disease on hemodialysis.\\nKeywords: Ferric citrate, Hemodialysis Phosphate binder\",\"PeriodicalId\":443152,\"journal\":{\"name\":\"Sumer 1\",\"volume\":\"410 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sumer 1\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21931/rb/css/2023.08.01.78\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sumer 1","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21931/rb/css/2023.08.01.78","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

背景:不受控制的高磷血症是终末期肾脏疾病患者血液透析治疗人员面临的主要困难。Sevelamer和含钙磷酸盐粘合剂分别与成本负担和组织钙化有关。因此，目前的试验旨在研究一种新的磷酸盐粘合剂柠檬酸铁在伊拉克终末期肾病患者血液透析中的疗效。关键词:柠檬酸铁;血液透析;磷酸盐结合剂

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The role of ferric citrate in a sample of Iraqi patients on hemodialysis- A randomized controlled clinical trial

Background: Uncontrolled hyperphosphatemia is the main difficulty facing staff treating patients with end-stage renal disease on hemodialysis. Sevelamer and calcium-containing phosphate binders have been associated with cost burden and tissue calcification, respectively. Therefore, the current trial was targeted to investigate the efficacy of a new phosphate binder, ferric citrate, in a sample of Iraqi patients with end-stage renal disease on hemodialysis. Keywords: Ferric citrate, Hemodialysis Phosphate binder

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Sumer 1

自引率

0.00%

发文量